Anti-parasitic drug discovery takes a giant leap forward

J Lipid Res. 2019 May;60(5):919-921. doi: 10.1194/jlr.C094250. Epub 2019 Mar 27.

Author

Joseph T Nickels Jr¹

Affiliation

¹ Institute of Metabolic Disorders, Genesis Biotechnology Group, Hamilton, NJ 08691, and Rutgers Center for Lipid Research, New Jersey Institute for Food, Nutrition, and Health, Rutgers University, New Brunswick, NJ 08901. Electronic address: jnickels@venenumbiodesign.com.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Acanthamoeba*
Anti-Bacterial Agents
Antimetabolites
Drug Discovery*
Phylogeny

Substances

Anti-Bacterial Agents
Antimetabolites